Gerresheimer Continues to Invest in Prefilled SyringesBy Gerresheimer Ag, PRNE
Wednesday, November 24, 2010
A Fourth Production Line for Prefilled Glass Syringes is Planned for the Bünde Plant (Germany)
DUSSELDORF, Germany, November 25, 2010 - Gerresheimer AG, one of the world's leading suppliers to the
pharma and healthcare industry, is making further investments in the growth
market for prefilled syringes. The three existing production lines for RTF(R)
syringes (Ready-To-Fill syringes) at the Bünde plant (Germany) are now to be
supplemented by an additional, latest-generation line.
Double-digit rates of annual growth are being recorded in the
prefilled glass syringe market. Gerresheimer, the clear number two in the
global market, is now stepping up its production capacity and investing
around EUR 20 million in a fourth production line for prefilled syringes
which will be completed in 2012. The new line will then add an annual
capacity of up to 120 million syringes.
"We are a successful supplier of syringes to pharmaceutics
customers around the world. Now we are investing in this fast-growing market
again to consolidate our global market position further. The technical
know-how of our Syringe Competence Centre in Bünde makes it the ideal
platform for further growth," said Uwe Röhrhoff, CEO of Gerresheimer AG.
More information on prefilled syringes at:
Gerresheimer AG Benrather Strasse 18 - 20 40213 Düsseldorf Germany Jens Kürten Director Corporate Communication & Marketing Telephone +49-211-6181-250 Telefax +49-211-6181-241 E-Mail firstname.lastname@example.org
Gerresheimer AG, Benrather Strasse 18 - 20, 40213 Düsseldorf, Germany, Jens Kürten, Director Corporate Communication & Marketing, Telephone +49-211-6181-250, Telefax +49-211-6181-241, E-Mail j.kuerten at gerresheimer.com
Tags: Dusseldorf, Germany, Gerresheimer AG, November 25